Star Matrix vs Autogenous Graft for Gingival Augmentation: Split-Mouth RCT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Star Matrix vs Autogenous Graft for Gingival Augmentation: Split-Mouth RCT — Stella

Recruiting

Back to Lack of Keratinized Gingiva trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Harvard Dental Center, Boston, Massachusetts

Key details

Sponsor

Harvard Medical School (HMS and HSDM)

Enrollment target

~12 participants

Started

November 2025

Primary completion

May 2026

Age range

20 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov